"mRNA technology is a good fit for gene editing. We want to make these editing proteins for just a short period of time to modify the genome. And producing the editing enzymes transiently helps to reduce the potential for off-target effects."
Ralph Baric | What Does Patent US-7279327-B2 Exist (Methods for Producing Recombinant Coronavirus)? Why Was Remdesivir Used As the Recommended COVID-19 Treatment?